Do analysts prefer NKGN or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NKGen Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer NKGN or JAGX?

In the previous week, NKGen Biotech and NKGen Biotech both had 1 articles in the media. Jaguar Animal Health's average media sentiment score of 0.49 beat NKGen Biotech's score of 0.21 indicating that Jaguar Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NKGen Biotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Jaguar Animal Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer RVPH or JAGX?

Reviva Pharmaceuticals currently has a consensus price target of $66.67, suggesting a potential upside of 9,566.04%. Given Reviva Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Reviva Pharmaceuticals is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Reviva Pharmaceuticals 1 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to RVPH or JAGX?

In the previous week, Reviva Pharmaceuticals and Reviva Pharmaceuticals both had 1 articles in the media. Jaguar Animal Health's average media sentiment score of 0.49 beat Reviva Pharmaceuticals' score of 0.38 indicating that Jaguar Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Reviva Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Jaguar Animal Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend ATON or JAGX?

Portage Biotech presently has a consensus target price of $2.00, suggesting a potential upside of 502.41%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities analysts clearly believe Portage Biotech is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate TNFA or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer JAGX or ASBP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aspire Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Jaguar Animal Health (JAGX) Competitors

$2.73 -0.07 (-2.50%)

Closing price 04:00 PM Eastern

Extended Trading

$2.74 +0.02 (+0.55%)

As of 06:31 PM Eastern

Compare

JAGX vs. NKGN, RVPH, ATON, TNFA, and ASBP

Should you buy Jaguar Animal Health stock or one of its competitors? MarketBeat compares Jaguar Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jaguar Animal Health include NKGen Biotech (NKGN), Reviva Pharmaceuticals (RVPH), Portage Biotech (ATON), TNF Pharmaceuticals (TNFA), and Aspire Biopharma (ASBP). These companies are all part of the "pharmaceutical products" industry.

How does Jaguar Animal Health compare to NKGen Biotech?

NKGen Biotech (NYSE:NKGN) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

NKGen Biotech has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, meaning that its stock price is 109% less volatile than the broader market.

In the previous week, NKGen Biotech and NKGen Biotech both had 1 articles in the media. Jaguar Animal Health's average media sentiment score of 0.49 beat NKGen Biotech's score of 0.21 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NKGen Biotech	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

76.2% of NKGen Biotech shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 10.4% of NKGen Biotech shares are owned by insiders. Comparatively, 2.1% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

NKGen Biotech has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. NKGen Biotech's return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NKGen Biotech	N/A	N/A	-479.36%
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NKGen Biotech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jaguar Animal Health has higher revenue and earnings than NKGen Biotech. NKGen Biotech is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NKGen Biotech	N/A	N/A	-$82.94M	-$1.51	N/A
Jaguar Animal Health	$29.54M	0.06	-$53.43M	-$591.92	N/A

Summary

NKGen Biotech and Jaguar Animal Health tied by winning 6 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Reviva Pharmaceuticals?

Reviva Pharmaceuticals (NASDAQ:RVPH) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

Reviva Pharmaceuticals currently has a consensus price target of $66.67, suggesting a potential upside of 9,566.04%. Given Reviva Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Reviva Pharmaceuticals is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Reviva Pharmaceuticals	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

63.2% of Reviva Pharmaceuticals shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 8.9% of Reviva Pharmaceuticals shares are owned by company insiders. Comparatively, 2.1% of Jaguar Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Reviva Pharmaceuticals has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market.

In the previous week, Reviva Pharmaceuticals and Reviva Pharmaceuticals both had 1 articles in the media. Jaguar Animal Health's average media sentiment score of 0.49 beat Reviva Pharmaceuticals' score of 0.38 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Reviva Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Reviva Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health. Reviva Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Reviva Pharmaceuticals	N/A	N/A	-$19.86M	-$4.06	N/A
Jaguar Animal Health	$29.54M	0.06	-$53.43M	-$591.92	N/A

Reviva Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Reviva Pharmaceuticals' return on equity of -391.58% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Reviva Pharmaceuticals	N/A	-391.58%	-119.08%
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

Summary

Reviva Pharmaceuticals beats Jaguar Animal Health on 10 of the 14 factors compared between the two stocks.

How does Jaguar Animal Health compare to Portage Biotech?

Portage Biotech (NASDAQ:ATON) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Portage Biotech has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Portage Biotech's return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

Portage Biotech presently has a consensus target price of $2.00, suggesting a potential upside of 502.41%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities analysts clearly believe Portage Biotech is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.4% of Portage Biotech shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 2.1% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Portage Biotech has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market.

Portage Biotech has higher earnings, but lower revenue than Jaguar Animal Health. Portage Biotech is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	N/A	N/A	-$6.77M	-$8.18	N/A
Jaguar Animal Health	$29.54M	0.06	-$53.43M	-$591.92	N/A

In the previous week, Jaguar Animal Health had 1 more articles in the media than Portage Biotech. MarketBeat recorded 1 mentions for Jaguar Animal Health and 0 mentions for Portage Biotech. Jaguar Animal Health's average media sentiment score of 0.49 beat Portage Biotech's score of 0.00 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Portage Biotech	Neutral
Jaguar Animal Health	Neutral

Summary

Portage Biotech beats Jaguar Animal Health on 10 of the 15 factors compared between the two stocks.

How does Jaguar Animal Health compare to TNF Pharmaceuticals?

TNF Pharmaceuticals (NASDAQ:TNFA) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

TNF Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. TNF Pharmaceuticals' return on equity of -69.21% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

TNF Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health. TNF Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
Jaguar Animal Health	$29.54M	0.06	-$53.43M	-$591.92	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Jaguar Animal Health had 1 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 1 mentions for Jaguar Animal Health and 0 mentions for TNF Pharmaceuticals. Jaguar Animal Health's average media sentiment score of 0.49 beat TNF Pharmaceuticals' score of 0.00 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Overall Sentiment
TNF Pharmaceuticals	Neutral
Jaguar Animal Health	Neutral

TNF Pharmaceuticals has a beta of 2.04, suggesting that its share price is 104% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market.

9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 2.1% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

TNF Pharmaceuticals and Jaguar Animal Health tied by winning 6 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Aspire Biopharma?

Jaguar Animal Health (NASDAQ:JAGX) and Aspire Biopharma (NASDAQ:ASBP) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are held by institutional investors. 2.1% of Jaguar Animal Health shares are held by company insiders. Comparatively, 5.8% of Aspire Biopharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aspire Biopharma has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Aspire Biopharma's return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%
Aspire Biopharma	N/A	N/A	-398.04%

In the previous week, Jaguar Animal Health had 1 more articles in the media than Aspire Biopharma. MarketBeat recorded 1 mentions for Jaguar Animal Health and 0 mentions for Aspire Biopharma. Jaguar Animal Health's average media sentiment score of 0.49 beat Aspire Biopharma's score of 0.00 indicating that Jaguar Animal Health is being referred to more favorably in the media.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
Aspire Biopharma	Neutral

Jaguar Animal Health has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, Aspire Biopharma has a beta of 0.17, indicating that its share price is 83% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aspire Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Aspire Biopharma has lower revenue, but higher earnings than Jaguar Animal Health. Aspire Biopharma is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$29.54M	0.06	-$53.43M	-$591.92	N/A
Aspire Biopharma	$10K	864.50	-$24.48M	-$116.67	N/A

Summary

Aspire Biopharma beats Jaguar Animal Health on 8 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.65M	$2.94B	$6.43B	$12.05B
Dividend Yield	N/A	1.69%	2.67%	5.56%
P/E Ratio	0.00	17.68	23.75	23.75
Price / Sales	0.06	297.77	479.79	84.65
Price / Cash	N/A	56.17	26.99	37.25
Price / Book	-0.03	3.83	10.28	6.78
Net Income	-$53.43M	$75.85M	$3.57B	$337.51M
7 Day Performance	-16.51%	-4.53%	-1.45%	-2.72%
1 Month Performance	-9.00%	-5.85%	3.25%	1.87%
1 Year Performance	-98.08%	15.32%	23.34%	26.60%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.5617 of 5 stars	$2.73 -2.5%	N/A	-98.0%	$1.65M	$29.54M	N/A	50	Gap Up
NKGN NKGen Biotech	N/A	$0.06 flat	N/A	-82.4%	$7.84M	N/A	N/A	N/A
RVPH Reviva Pharmaceuticals	2.5478 of 5 stars	$0.60 -0.8%	$66.67 +11,104.5%	-95.6%	$7.80M	N/A	N/A	5	Positive News Analyst Downgrade Gap Up
ATON Portage Biotech	N/A	$0.33 +3.8%	$2.00 +502.4%	N/A	$7.78M	N/A	N/A	6	Gap Up High Trading Volume
TNFA TNF Pharmaceuticals	N/A	$4.20 -3.9%	N/A	-77.9%	$7.76M	N/A	N/A	6

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 6/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. NKGN, RVPH, ATON, TNFA, and ASBP

How does Jaguar Animal Health compare to NKGen Biotech?

Summary

How does Jaguar Animal Health compare to Reviva Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Portage Biotech?

Summary

How does Jaguar Animal Health compare to TNF Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Aspire Biopharma?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. NKGN, RVPH, ATON, TNFA, and ASBP

How does Jaguar Animal Health compare to NKGen Biotech?

Which has more volatility and risk, NKGN or JAGX?

Does the media prefer NKGN or JAGX?

Do insiders & institutionals have more ownership in NKGN or JAGX?

Is NKGN or JAGX more profitable?

Do analysts prefer NKGN or JAGX?

Which has preferable valuation & earnings, NKGN or JAGX?

Summary

How does Jaguar Animal Health compare to Reviva Pharmaceuticals?

Do analysts prefer RVPH or JAGX?

Do institutionals and insiders have more ownership in RVPH or JAGX?

Which has more volatility & risk, RVPH or JAGX?

Does the media refer more to RVPH or JAGX?

Which has higher valuation and earnings, RVPH or JAGX?

Is RVPH or JAGX more profitable?

Summary

How does Jaguar Animal Health compare to Portage Biotech?

Is ATON or JAGX more profitable?

Do analysts recommend ATON or JAGX?

Do insiders & institutionals have more ownership in ATON or JAGX?

Which has more volatility & risk, ATON or JAGX?

Which has preferable valuation & earnings, ATON or JAGX?

Does the media refer more to ATON or JAGX?

Summary

How does Jaguar Animal Health compare to TNF Pharmaceuticals?

Is TNFA or JAGX more profitable?

Which has higher earnings and valuation, TNFA or JAGX?

Do analysts rate TNFA or JAGX?

Does the media favor TNFA or JAGX?

Which has more volatility & risk, TNFA or JAGX?

Do insiders and institutionals have more ownership in TNFA or JAGX?

Summary

How does Jaguar Animal Health compare to Aspire Biopharma?

Do institutionals & insiders hold more shares of JAGX or ASBP?

Is JAGX or ASBP more profitable?

Does the media refer more to JAGX or ASBP?

Which has more volatility and risk, JAGX or ASBP?

Do analysts prefer JAGX or ASBP?

Which has stronger valuation & earnings, JAGX or ASBP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools